Brief: Xortx Files New Percent Patent To Treat And Protect Individuals Most At Risk To Severe Viral Infection
23/03/2022 11:09
March 23 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX FILES NEW PERCENT PATENT TO TREAT AND PROTECT
INDIVIDUALS
MOST AT RISK TO SEVERE VIRAL INFECTION
Source text for Eikon: ID:nGNX2YcDT5
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering